Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP645821.RAg7N84JgRpwNY9EZj5o9gvcc-fS_wJgzSSAfRbVNlUXU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP645821.RAg7N84JgRpwNY9EZj5o9gvcc-fS_wJgzSSAfRbVNlUXU130_assertion type Assertion NP645821.RAg7N84JgRpwNY9EZj5o9gvcc-fS_wJgzSSAfRbVNlUXU130_head.
- NP645821.RAg7N84JgRpwNY9EZj5o9gvcc-fS_wJgzSSAfRbVNlUXU130_assertion description "[The clinical relevance could include the use of locally administered HGF/SF in protein or gene form to minimize formation of keloids.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645821.RAg7N84JgRpwNY9EZj5o9gvcc-fS_wJgzSSAfRbVNlUXU130_provenance.
- NP645821.RAg7N84JgRpwNY9EZj5o9gvcc-fS_wJgzSSAfRbVNlUXU130_assertion evidence source_evidence_literature NP645821.RAg7N84JgRpwNY9EZj5o9gvcc-fS_wJgzSSAfRbVNlUXU130_provenance.
- NP645821.RAg7N84JgRpwNY9EZj5o9gvcc-fS_wJgzSSAfRbVNlUXU130_assertion SIO_000772 18087663 NP645821.RAg7N84JgRpwNY9EZj5o9gvcc-fS_wJgzSSAfRbVNlUXU130_provenance.
- NP645821.RAg7N84JgRpwNY9EZj5o9gvcc-fS_wJgzSSAfRbVNlUXU130_assertion wasDerivedFrom befree-2016 NP645821.RAg7N84JgRpwNY9EZj5o9gvcc-fS_wJgzSSAfRbVNlUXU130_provenance.
- NP645821.RAg7N84JgRpwNY9EZj5o9gvcc-fS_wJgzSSAfRbVNlUXU130_assertion wasGeneratedBy ECO_0000203 NP645821.RAg7N84JgRpwNY9EZj5o9gvcc-fS_wJgzSSAfRbVNlUXU130_provenance.